Keywords: Nycomed, First-quarter 201 financial results, Takeda

Emerging markets continue to drive Nycomed in first quarter 2011

Article | 26 May 2011

Print This

Independent Swiss drugmaker Nycomed, which is the subject of an agreed 9.6 billion-euro takeover by Japan’s Takeda (TYO: 4502; The ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in